BusinessAlder BioPharmaceuticals Presents Positive Phase 2b Study Data for Eptinezumab at 69th Annual American Academy of Neurology MeetingBy Nasdaq OMXApr 28, 2017, 5:24 PM UTC
BusinessIntercept to Report First Quarter 2017 Financial Results on May 4 and Present at Upcoming ConferenceBy Nasdaq OMXApr 27, 2017, 9:00 PM UTC
BusinessMyriad Genetics and Clovis Oncology Sign Agreement for Use of FDA-Approved BRACAnalysis CDx® Test to Identify Patients with Germline BRCA Mutations for Rubraca® (rucaparib) TreatmentBy Nasdaq OMXApr 27, 2017, 11:05 AM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:03 AM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:03 AM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:03 AM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:02 AM UTC
BusinessMacroGenics Announces Registered Direct Offering of Common StockBy Nasdaq OMXApr 27, 2017, 11:02 AM UTC
